Lip Yong Chung
Overview
Explore the profile of Lip Yong Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
775
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chellathurai M, Chung L, Hilles A, Sofian Z, Singha S, Ghosal K, et al.
Int J Biol Macromol
. 2024 Sep;
280(Pt 2):135775.
PMID: 39307491
Chitosan (CS) has become a focal point of extensive research in the pharmaceutical industry due to its remarkable biodegradability, biocompatibility and sustainability. Chitosan hydrogels (CS HGs) are characterized by their...
2.
Fatemi K, Lau S, Obayomi K, Kiew S, Coorey R, Chung L, et al.
Anal Biochem
. 2024 Aug;
695:115639.
PMID: 39127327
Each year, millions of people suffer from foodborne illness due to the consumption of food contaminated with pathogenic bacteria, which severely challenges global health. Therefore, it is essential to recognize...
3.
Manimaran M, Teo Y, Kah J, Beishenaliev A, Loke Y, Foo Y, et al.
Int J Nanomedicine
. 2024 Apr;
19:3697-3714.
PMID: 38681091
Introduction: Over 75% of clinical microbiological infections are caused by bacterial biofilms that grow on wounds or implantable medical devices. This work describes the development of a new poly(diallyldimethylammonium chloride)...
4.
Beishenaliev A, Loke Y, Goh S, Geo H, Mugila M, Misran M, et al.
J Control Release
. 2023 May;
359:268-286.
PMID: 37244297
Monospecific antibodies have been utilised increasingly for anti-cancer drug targeting owing to their ability to minimise off-target toxicity by binding specifically to a tumour epitope, hence selectively delivering drugs to...
5.
Loke Y, Beishenaliev A, Wang P, Lin C, Chang C, Foo Y, et al.
Ultrason Sonochem
. 2023 May;
96:106437.
PMID: 37187119
Sonodynamic therapy (SDT) emerges as a promising non-invasive alternative for eradicating malignant tumours. However, its therapeutic efficacy remains limited due to the lack of sonosensitisers with high potency and biosafety....
6.
Anasamy T, Chee C, Kiew L, Chung L
Eur J Pharm Sci
. 2022 Nov;
181:106320.
PMID: 36336567
No abstract available.
7.
Saw W, Anasamy T, Do T, Lee H, Chee C, Isci U, et al.
Macromol Biosci
. 2022 May;
22(8):e2200130.
PMID: 35579182
A critical factor in developing an efficient photosensitizer-gold nanoparticle (PS-AuNP) hybrid system with improved plasmonic photosensitization is to allocate a suitable space between AuNPs and PS. Poly(amidoamine) (PAMAM) dendrimer is...
8.
Geo H, Murugan D, Chik Z, Norazit A, Foo Y, Leo B, et al.
J Control Release
. 2022 Jan;
343:237-254.
PMID: 35085695
Acute kidney injury (AKI) causes considerable morbidity and mortality, particularly in the case of post-cardiac infarction or kidney transplantation; however, the site-specific accumulation of small molecule reno-protective agents for AKI...
9.
Fong S, Foo Y, Saw W, Leo B, Teo Y, Chung I, et al.
Int J Nanomedicine
. 2022 Jan;
17:137-150.
PMID: 35046650
Purpose: The use of nanocarriers to improve the delivery and efficacy of antimetastatic agents is less explored when compared to cytotoxic agents. This study reports the entrapment of an antimetastatic...
10.
Lai P, Usama S, Kiew L, Lee H, Chung L, Burgess K, et al.
Cancer Immunol Immunother
. 2022 Jan;
71(9):2099-2108.
PMID: 35032175
Conventional cancer therapies such as chemotherapy are non-selective and induce immune system anergy, which lead to serious side effects and tumor relapse. It is a challenge to prime the body's...